Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIcg-longbow Regulatory News (LBOW)

Share Price Information for Icg-longbow (LBOW)

Share Price is delayed by 15 minutes
Get Live Data
12.50    0.00 (0.00%)
Bid:
11.10
Ask:
14.00
Spread: 2.90 (26.126%)
Market Cap: £15.16m
LBOW Live PriceLast checked at - London Stock Exchange

Intraday Icg-longbow Share Chart

Portfolio Update & Board Changes

30 Jan 2025 18:05

RNS Number : 3610V
ICG-Longbow Snr Sec UK Prop DebtInv
30 January 2025
 

ICG Longbow LEI: 2138008BKBH3OP2CA764

30 January 2025

 

 

ICG-Longbow Senior Secured UK Property Debt Investments Limited

 

(the "Company")

Portfolio Update and Board Changes

Portfolio Update

The Company continues to make progress in exiting its three final investments in what remain challenging market conditions. 

 

Since issuance of the Company's interim report and accounts in October 2024, the asset securing the Affinity loan has been placed under offer for sale following a competitive bidding process, and the Company continues to see buyer interest for the Southport hotel asset, however the exit of this position is taking longer than anticipated. 

 

The Company, its fellow lenders and the operating partner continue to work together to restabilise the portfolio securing the RoyaleLife loan under the new Regency Living brand, with home sales having restarted in earnest in the fourth quarter of 2024. An exit of this portfolio is anticipated when the conditions are right for sale.

 

Board Changes

The board has sought to control the cost base of the Company as assets have shrunk. As noted above, some progress is being made in relation to the remaining three loans and, accordingly, the board has agreed that it is an appropriate time to reduce the size of the board.

 

Stuart Beevor, who has served as Director and Fiona Le Poidevin, who has served as a Director and Chair of the Audit and Risk Committee, will retire from the Board of the Company with effect from 31 January 2025. 

 

Jack Perry and Paul Meader will remain as Directors.

 

The Company also announces the following changes to the roles and responsibilities of some Directors with effect from 31 January 2025, in accordance with listing rule 6.4.6 (2) & (3):

 

Paul Meader will be appointed as Chair of the Audit and Risk Committee with effect from 31 January 2025 following Fiona Le Poidevin's retirement.

 

The Company extends its thanks to Stuart and Fiona for their hard work and wise counsel during their tenures.

 

For further information, please contact:

Ocorian Administration (Guernsey) Limited:

Louise Manklow

+44 (0)14 8174 2742

 

Cavendish:

James King

Daniel Balabanoff

+44 (0)20 7397 1910

+44 (0)20 7397 1909

 

ICG Real Estate:

David Mortimer

 

 

+44 (0)20 3545 138

 

 

Further information on the Company can be found on its website at http://www.lbow.co.uk/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBMMPTMTMJBJA
Date   Source Headline
1st Jun 20262:46 pmRNSNotice of AGM
7th May 20267:00 amRNSAnnual Report & Financial Statements 31 Jan 2026
30th Sep 20257:00 amRNSHalf-year Report
6th Aug 202512:46 pmRNSHolding(s) in Company
27th Jun 20251:18 pmRNSReturn of Capital and NAV
20th Jun 20254:40 pmRNSHolding(s) in Company
19th Jun 20252:10 pmRNSResults of Annual General Meeting
2nd Jun 20253:54 pmRNSNotice of Annual General Meeting
29th May 202510:04 amRNSPortfolio Update
1st May 20257:00 amRNSAnnual Report & Financial Statements 31 Jan 2025
30th Jan 20256:05 pmRNSPortfolio Update & Board Changes
29th Oct 20244:34 pmRNSDirector Declaration
3rd Oct 20241:55 pmRNSInterim Report
18th Jun 20241:30 pmRNSResult of AGM
15th May 20247:00 amRNSNotice of AGM
10th May 202412:59 pmRNSHolding(s) in Company
9th May 20247:00 amRNSAnnual Financial Report
13th Dec 20237:00 amRNSPortfolio Update
3rd Oct 20237:00 amRNSHalf-year Report
25th Sep 202311:37 amRNSPortfolio Update
15th Aug 20232:54 pmRNSPortfolio Update
11th Aug 20237:00 amRNSReturn of Capital and NAV
20th Jun 20236:02 pmRNSTrading Update
20th Jun 20236:00 pmRNSResults of AGM
26th May 20239:00 amRNSNotice of AGM
22nd May 20236:29 pmRNSAnnual Report for the year ended 31 January 2023
12th May 20237:00 amRNSPortfolio Update
6th Apr 20233:38 pmRNSDividend Announcement and Portfolio Update
26th Jan 20237:00 amRNSReturn of Capital and NAV
20th Jan 20239:25 amRNSHolding(s) in Company
16th Jan 20237:00 amRNSPortfolio Update
13th Dec 20228:00 amRNSDirector Declaration
7th Dec 20227:00 amRNSQuarterly Update
1st Dec 20221:52 pmRNSInterim Dividend Declaration
23rd Sep 20227:00 amRNSHalf-year Report
23rd Sep 20227:00 amRNSHalf-year Report
21st Sep 20222:51 pmRNSInterim Dividend Announcement
14th Sep 20227:00 amRNSQuarterly Update
2nd Aug 20221:07 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSInterim Dividend Declaration
22nd Jun 20225:57 pmRNSResults of AGM
16th Jun 20227:00 amRNSQuarterly Update
26th May 20224:41 pmRNSSecond Price Monitoring Extn
26th May 20224:36 pmRNSPrice Monitoring Extension
25th May 20224:10 pmRNSNotice of AGM
20th May 20227:00 amRNSAnnual Report for the year ended 31 January 2022
18th May 202210:04 amRNSReturn of Capital and NAV
6th May 20225:55 pmRNSHolding(s) in Company
26th Apr 20222:48 pmRNSPortfolio Update
6th Apr 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.